BioClavis

BioClavis is a private Glasgow-based biotechnology and precision diagnostics company that provides transcriptomic and genomic profiling services for drug discovery, biomarker discovery, and companion diagnostic development. The company is a spin-out/subsidiary created from BioSpyder Technologies and commercializes services built around the proprietary TempO-Seq platform. Its technology is designed for high-throughput gene expression analysis from difficult sample types such as FFPE tissue, whole blood, frozen tissue, and crude lysates without conventional nucleic acid extraction. BioClavis serves pharmaceutical, academic, and clinical research customers and is also developing its own precision diagnostic and companion diagnostic opportunities. The business appears to be primarily a platform and services company rather than a therapeutics developer.